New Resource:

Checklist for Pediatric COVID-19 Vaccination

Resource Details


Collaboration Between Medical-Legal Partnerships, FQHCs, and Domestic Violence Programs to Support Patients

Resource Topic: Clinical Issues, Social Determinants of Health (SDOH), Special and Vulnerable Populations

Resource Subtopic: Policy and Advocacy, Enabling Services (ES), Programs and Services.

Keywords: Access to Care, Legal Issues, Medical Legal Partnerships (MLPs), Non-Clinical Services, Partnerships.

Year Developed: 2021

Resource Type: In-Person Training.

Primary Audience: Clinicians Enabling Staff Outreach Staff PCAs
Secondary Audience: Administrative Staff Board of Directors C-Suite (CEOs, CFOs, CIO, COOs, CMOs, etc.)

Language: English

Developed by: National Center for Medical-Legal Partnership (See other resources developed by this organization).

Resource Summary: Through this national webinar, the National Center for Medical-Legal Partnership (NCMLP) and Futures Without Violence (FUTURES) joined forces to share strategies on how MLPs can successfully partner with FQHCs and community-based domestic violence programs to improve health outcomes, decrease isolation, and support health care for survivors. Presenters highlighted how civil legal service providers partner with FQHCs to address the increased needs of individuals affected by IPV/HT during COVID-19.

Resource Details: In this webinar, we heard from Elena Josway and Kimberly S.G. Chang from Futures Without Violence on ways to promote collaboration between domestic violence service providers, medical-legal partnerships, and community health centers. They also provided resources and highlighted practical strategies that community health centers and medical-legal partnership staff can implement to address the needs of survivors and promote prevention. A brief Q&A session brought the webinar to a close.

This project is supported by the Health Resources and Services Administration (HRSA) of the U.S. Department of Health and Human Services (HHS) as part of an award totaling $6,625,000 with 0 percentage financed with non-governmental sources. The contents are those of the author(s) and do not necessarily represent the official views of, nor an endorsement, by HRSA, HHS, or the U.S. Government. For more information, please visit